LIXISENATIDE SANOFI TREATMENT INITIATION PACK 10mcg (0.05 mg/mL) and 20 mcg (0.1) mg/mL solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi treatment initiation pack 10mcg (0.05 mg/ml) and 20 mcg (0.1) mg/ml solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

Insulin lispro Sanofi European Union - English - EMA (European Medicines Agency)

insulin lispro sanofi

sanofi winthrop industrie - insulin lispro - diabetes mellitus - drugs used in diabetes - for the treatment of adults and children with diabetes mellitus who require insulin for the maintenance of normal glucose homeostasis. insulin lispro sanofi is also indicated for the initial stabilisation of diabetes mellitus.

LIXISENATIDE SANOFI lixisenatide 20 mcg (0.1 mg/mL) solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 20 mcg (0.1 mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

LIXISENATIDE SANOFI lixisenatide 10 mcg (0.05mg/mL) solution for injection injector pen Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi lixisenatide 10 mcg (0.05mg/ml) solution for injection injector pen

sanofi-aventis australia pty ltd - lixisenatide -

TERIFLUNOMIDE SANOFI teriflunomide 14 mg film-coated tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

teriflunomide sanofi teriflunomide 14 mg film-coated tablets blister pack

sanofi-aventis australia pty ltd - teriflunomide -

Insulin aspart Sanofi European Union - English - EMA (European Medicines Agency)

insulin aspart sanofi

sanofi winthrop industrie - insulin aspart - diabetes mellitus - drugs used in diabetes - insulin aspart sanofi is indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above.

LIXISENATIDE SANOFI Australia - English - Department of Health (Therapeutic Goods Administration)

lixisenatide sanofi

sanofi-aventis australia pty ltd - lixisenatide -

Acomplia European Union - English - EMA (European Medicines Agency)

acomplia

sanofi-aventis - rimonabant - obesity - antiobesity preparations, excl. diet products - as an adjunct to diet and exercise for the treatment of obese patients (bmi 30 kg/m2), or overweight patients (bmi 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).

Zimulti European Union - English - EMA (European Medicines Agency)

zimulti

sanofi-aventis - rimonabant - obesity - antiobesity preparations, excl. diet products - as an adjunct to diet and exercise for the treatment of obese patients (bmi 30 kg/m2), or overweight patients (bmi 27 kg/m2) with associated risk factor(s), such as type 2 diabetes or dyslipidaemia (see section 5.1).

Teriflunomide Sanofi Australia - English - Department of Health (Therapeutic Goods Administration)

teriflunomide sanofi

sanofi-aventis australia pty ltd - teriflunomide -